Stellar Quarter for Anheuser-Busch, Though Risk Remains
The wide-moat brewing company had an encouraging performance in the third quarter. We retain our fair value estimate.
Anheuser-Busch InBev (BUD), or AB InBev, the world's largest brewer, blew away S&P Capital IQ consensus estimates in the third quarter, with a remarkably robust volume. There was also modest upside to our above-consensus estimates, with pleasing volume growth in both Brazil and the U.S., the firm's two largest markets. While this is clearly a big step in the right direction, we suspect that to a degree, shipments were propped up by subsidies to consumers and channel restocking, and we expect market volatility to remain for the next few quarters. The suspension of the interim dividend supports this view. Nevertheless, this was a strong quarter from a frim that has offered precious little good news in the last few years. We have made minor adjustments to our assumptions, mainly to reflect the more difficult comparable AB InBev will now face in 2021, and retain our USD 96 fair value estimate for the ADRs, as well as our wide moat rating.
Although these are far from normal times, AB InBev performed in line with our assumptions for its normalised environment in the third quarter; an encouraging performance. Third-quarter organic revenue grew 4% year over year, comfortably above our forecast of essentially flat revenue. The upside was driven by volume, which grew 1.9% organically on a consolidated basis, with upside in both North and South America. All other regions performed in line with our forecasts. Crucially, the key markets we think are important to a rerating of AB InBev's market valuation performed well. In the U.S., 1.4% volume growth implies 25 basis points of volume share gain, in spite of a respectable 3.5% positive price/mix, AB InBev's best performance in the U.S. for some time. The share gains across the portfolio were impressive, as AB InBev outperformed across multiple beer segments, as well as in seltzer. Share stability in the U.S. could be a catalyst for the stock, but we caution that the rebound of the on-trade could pose a risk to AB InBev's share.
|Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.|
Philip Gorham does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.